IWFS:LSE:LSE-iShares MSCI World Size Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 3784.5

Change

+15.00 (+0.40)%

Market Cap

USD 0.28B

Volume

2.81K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-28.00 (-12.84%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.10 (+0.80%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.46%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.32%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.39%)

USD 266.08B
0QZO:LSE 0QZO

+1.20 (+1.12%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.56%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+1.52 (+0.92%)

USD 202.26B
0R24:LSE Intel Corp.

-0.28 (-1.26%)

USD 196.14B

ETFs Containing IWFS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.37% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.37% 72% C 69% C-
Trailing 12 Months  
Capital Gain 15.07% 61% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.07% 60% D- 63% D
Trailing 5 Years  
Capital Gain 36.55% 59% D- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.55% 57% F 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.45% 57% F 62% D
Dividend Return 8.45% 57% F 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.56% 56% F 73% C
Risk Adjusted Return 67.25% 68% D+ 80% B-
Market Capitalization 0.28B 65% D 37% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike